News tagged with interferon therapy
Mutations within a conservative region of HCV affects the therapy
Mar 30, 2009 |
not rated yet |
0
At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy. Response to interferon therapy depends ...
Search results for interferon therapy
Gamma interferon could aid fight against fungal infections
Biology /
Oct 31, 2007 |
4.3 / 5 (3) |
0
Interferon, the “superhero” cure for viral infections, may be a strong weapon in the battle against fungal infections in immunocompromised patients, according to an article in the November issue of Microbiology Today.
Good news for some hard-to-treat hepatitis C patients
Jun 16, 2009 |
not rated yet |
0
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to ...
Two-day results predict ultimate response to therapy in chronic hepatitis C
Mar 20, 2009 |
not rated yet |
0
A new study suggests that previously noted low rates of successful hepatitis C virus (HCV) therapy in African Americans are in large part due to very early differences in the antiviral activity induced by interferon. The ...
Scientists shine new light on inflammatory diseases
Mar 16, 2008 |
4.3 / 5 (3) |
0
Investigators at Hospital for Special Surgery have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. The mechanism may also shed some light on why gene therapy ...
Genetic differences may help explain response to multiple sclerosis treatment
Jan 14, 2008 |
5 / 5 (1) |
0
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences ...
Interferon could be a key to preventing or treating multiple sclerosis
Oct 30, 2008 |
4 / 5 (3) |
0
Multiple sclerosis (MS) results when the body's own defense system attacks nerve fibers in the brain and spinal cord. Now scientists led by John Russell, Ph.D., at Washington University School of Medicine in St. Louis have ...
New treatment option for patients with chronic hepatitis C
May 28, 2009 |
not rated yet |
0
A new combination therapy of daily consensus interferon (CIFN) and ribavirin is effective for some people with chronic hepatitis C (HCV) who do not respond to standard therapy. The treatment works particularly well in interferon-sensitive ...
Using math to understand hep. C: Patterns paint picture of who will respond to treatment
Dec 22, 2008 |
not rated yet |
0
Genetic patterns are like the tea leaves in the bottom of a cup for predicting which patients are likely to respond to medical therapy for life-threatening viruses such as hepatitis C, Saint Louis University researchers have ...
Short Strand of RNA May Help Predict Survival and Response to Treatment for Patients with Liver Cancer
Oct 08, 2009 |
not rated yet |
0
(PhysOrg.com) -- A small RNA molecule, known as a microRNA, may help physicians identify liver cancer patients who, in spite of their poor prognosis, could respond well to treatment with a biological agent called interferon. ...
Genetic breakthrough supercharges immunity to flu and other viruses
Feb 13, 2008 |
4.8 / 5 (30) |
0
Researchers at McGill University have discovered a way to boost an organism’s natural anti-virus defences, effectively making its cells immune to influenza and other viruses.
List of search results for interferon therapy
